CDD’s TBDA Collaboration with BMGF, Glaxo’s “Open Lab”& half-a-dozen Big Pharmas Highlighted in the Economist

January 23, 2013

The Economist’s Jan 12 Schumpeter series on world business trends highlighted the Gates Foundation.

bill-gates-foundation-world-health-problems1

 

Th Gates foundation is promoting collaboration with academics, non-profit, and government laboratories with 7 big pharmas!  The Economist mentions a specific publication by the World Economic Forum (which meets in Davos this month) which argues:

“that companies and non-profits need to collaborator more to develop more drugs…Glaxo has opened its Tres Cantos research facilities to academic and government scientists in order to collaborate on discovering new antibiotics.  The Gates Foundation has organised an accelerator programme that brings together research teams from academia and private companies such as Abbott Laboratories, AstraZeneca, Bayer, Eli Lilly and Glaxo.”

CDD is honored to be of service by pushing forward web-based technologies with the CDD Vault® to facilitate new modes of secure collaborations.  Read the full article in the Economist.

 

 

 

 

 

 

 


Ce blog est rédigé par des membres de la communauté CDD Vault. CDD Vault est une plateforme informatique hébergée de découverte de médicaments qui gère de manière sécurisée les données biologiques et chimiques privées et externes. Elle fournit des fonctionnalités de base, notamment l'enregistrement des produits chimiques, la relation structure-activitéLes capacités des ordinateurs portables, des inventaires chimiques et des carnets de laboratoire électroniques!

Chambre forte du CDD : Drug Discovery Informatics : toute votre équipe de projet va s'y mettre !